Literature DB >> 31096215

C-X-C Chemokine Receptor 4 in Diffuse Large B Cell Lymphoma: Achievements and Challenges.

Hui Du1, Lei Gao2, Jing Luan2, Hangfan Zhang2, Taiwu Xiao2.   

Abstract

Diffuse large B cell lymphoma (DLBCL), an aggressive cancer of the B cells, is the most common subtype of non-Hodgkin lymphoma (NHL) worldwide. In China, the cases of DLBCL increase yearly. C-X-C chemokine receptor 4 (CXCR4) has been implicated in the migration and trafficking of malignant B cells in several hematological malignancies, and only a few reports have been published on the role of CXCR4 in the metastasis of DLBCL. This review summarizes the relevant perspectives on the functional mechanism, prognostic significance, and therapeutic applications of the CXCL12/CXCR4 axis in DLBCL, in particular DLBCL with bone marrow involvement.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  C-X-C chemokinereceptor 4; CXCL12/CXCR4 axis; Diffuse large B cell lymphoma; Functional mechanism; Therapeutic applications

Mesh:

Substances:

Year:  2019        PMID: 31096215     DOI: 10.1159/000497430

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  3 in total

1.  The CXCR4-CXCL12-Axis Is of Prognostic Relevance in DLBCL and Its Antagonists Exert Pro-Apoptotic Effects In Vitro.

Authors:  Katrin Pansy; Julia Feichtinger; Barbara Ehall; Barbara Uhl; Miriam Sedej; David Roula; Beata Pursche; Axel Wolf; Manuel Zoidl; Elisabeth Steinbauer; Verena Gruber; Hildegard T Greinix; Katharina T Prochazka; Gerhard G Thallinger; Akos Heinemann; Christine Beham-Schmid; Peter Neumeister; Tanja M Wrodnigg; Karoline Fechter; Alexander Ja Deutsch
Journal:  Int J Mol Sci       Date:  2019-09-24       Impact factor: 5.923

Review 2.  Aberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom's Macroglobulinemia.

Authors:  Samantha Milanesi; Massimo Locati; Elena Monica Borroni
Journal:  Int J Mol Sci       Date:  2020-08-08       Impact factor: 5.923

3.  Somatostatin Receptors and Chemokine Receptor CXCR4 in Lymphomas: A Histopathological Review of Six Lymphoma Subtypes.

Authors:  Tiina Juntikka; Samuli Vaittinen; Tero Vahlberg; Sirkku Jyrkkiö; Heikki Minn
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.